Talis Biomedical extends waiver of registration rights with Baker Brothers through May 27, 2024

Talis Biomedical Corp

Company and Baker Brothers entities agree to extend waiver of registration rights originally set for 30 days.
Waiver now runs through May 27, 2024, covering all registrable securities beneficially owned by the stockholders.
Extension follows termination of S-3 registration statement in March 2024 due to company no longer being eligible.
Waiver applies to Sections 2.1(a) and 2.1(b) of the Registration Rights Agreement.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Talis Biomedical Corp amended Amendment to the Waiver Agreement with Baker Brothers Life Sciences L.P. and 667, L.P. valued at Extension of registration rights waiver through May 27, 2024 (effective 2024-04-29).

Action: amendment
Counterparty: Baker Brothers Life Sciences L.P. and 667, L.P.
Value: Extension of registration rights waiver through May 27, 2024
Effective: 2024-04-29

Exact text from the filing

On April 29, 2024, The Baker Funds agreed to extend this waiver through May 27, 2024 (the “Amendment to the Waiver Agreement”).

View on SEC.gov

292 material agreements filed in the last 30 days. Browse all material agreements →

Source: SEC EDGAR

accession 0000950170-24-052949

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.